T Cell-Tumor Interaction Directs the Development of Immunotherapies in Head and Neck Cancer
The competent immune system controls disease effectively due to induction, function, and regulation of effector lymphocytes. Immunosurveillance is exerted mostly by cytotoxic T-lymphocytes (CTLs) while specific immune suppression is associated with tumor malignancy and progression. In squamous cell...
Main Authors: | A. E. Albers, L. Strauss, T. Liao, T. K. Hoffmann, A. M. Kaufmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2010-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2010/236378 |
Similar Items
-
Tumor Microenvironment and Immunotherapy Response in Head and Neck Cancer
by: Panagiota Economopoulou, et al.
Published: (2020-11-01) -
Immunotherapy in Head and Neck Squamous Cell Cancer
by: Nerina Denaro, et al.
Published: (2018-12-01) -
A Quest for Initiating Cells of Head and Neck Cancer and Their Treatment
by: Andreas M. Kaufmann, et al.
Published: (2010-07-01) -
Advances in Head and Neck Cancer Immunology and Immunotherapy
Published: (2019) -
Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma.
by: Chao Chen, et al.
Published: (2011-01-01)